Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03418532
Title MP0250 DARPin Protein Plus Osimertinib in Patients With EGFR-mutated NSCLC
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Molecular Partners AG
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Scottsdale Healthcare Hospitals Scottsdale Arizona 85258 United States Details
City of Hope - Comprehensive Cancer Center Duarte California 91010 United States Details
University of California San Diego California 92093 United States Details
UCLA Medical Center Santa Monica California 90404 United States Details
Georgetown University Washington District of Columbia 20057 United States Details
Florida Hospital Orlando Florida 32803 United States Details
Duke Cancer Institute Durham North Carolina 27710 United States Details
Tennessee Oncology Nashville Tennessee 37203 United States Details
UT Southwestern Medical Center Dallas Texas 75390 United States Details
Oncology Consultants Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field